Table 3. The in vivo effect of mutations in the conserved region of MdsAa in the presence of wild-type MdsB and TolC without MdsC.
Background | ATCC14028SΔacrABΔmdsABC::Cm5 | |||
MdsA protein | MIC (µg/mL)b | |||
Crystal violet | Methylene blue | Acriflavine | Rhodamine 6G | |
Nonec | 4 | 32 | 16 | 4 |
MdsA-WT | 16 | 256 | 32 | 64 |
MdsA-R135D | 8 | 64 | 16 | 32 |
MdsA-L139D | 4 | 32 | 16 | 8 |
MdsA-S146D | 16 | 256 | 32 | 64 |
The in vivo effect of each mutation in the conserved region of MdsA was determined by measuring the resistance of the ATCC14028SΔacrABΔmdsABC::Cm5 strain to several substrates. MdsA and its variants were expressed from pMdsAB2, pMdsAB2 MdsA-R135D, pMdsAB2 MdsA-L139D, and pMdsAB2 MdsA-S146D.
All MIC measurements were done in triplicate. The concentrations of crystal violet and acriflavine used to determine the MICs were 0, 1, 2, 4, 8, 16, and 32 µg/mL. The concentrations of rhodamine 6G and methylene blue used to determine the MICs were 0, 4, 8, 16, 32, 64, 128, and 256 µg/mL.
None, strain carrying the empty vector pKAN6B instead of an pMdsAB2 variant.